|
| Press Releases |
|
 |
|
| Thursday, May 2, 2024 |
|
|
The 16th Annual Global CSR & ESG Summit and Awards 2024: Celebrating Sustainable Leadership and Innovation, 25 April 2024 |
| The 16th Annual Global CSR & ESG Summit and Awards 2024 came to a triumphal close, marking another milestone in the realm of achievable corporate social responsibility (CSR) and environmental, social, and governance (ESG) initiatives. more info >> |
|
| Thursday, June 29, 2023 |
|
|
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development |
| BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: "Next Generation Virtual Patient Engine for Clinical Translation of Drug Candidates" (VPE). more info >> |
|
| Tuesday, December 6, 2022 |
|
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
| Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National University of Singapore (NUS); Nanyang Technological University, Singapore (NTU Singapore) and its innovation and enterprise company, NTUitive; and Singapore Institute of Technology (SIT) to boost Singapore's biologics manufacturing capabilities. more info >> |
|
| Monday, April 19, 2021 |
|
|
Sanofi Renews Partnership with Cielo to Strengthen its Talent Acquisition Strategy in Asia |
| Cielo, the world's leading Recruitment Process Outsourcing (RPO) provider, has renewed its partnership with Sanofi, a global biopharmaceutical company, to help them hire the best talent in Asia. more info >> |
|
| Friday, April 26, 2019 |
|
|
Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER |
| Sanofi delivered strong Q1 2019 business EPS growth of 9.4% at CER. more info >> |
|
| Thursday, February 7, 2019 |
|
|
Sanofi delivers 2018 business EPS growth of 5.1% at CER |
| Sanofi announced the 2018 fourth-quarter and full-year results. more info >> |
|
| Wednesday, February 7, 2018 |
|
|
Sanofi Delivers 2017 Business EPS in line with Guidance |
| Sanofi Delivers 2017 Business EPS in line with Guidance more info >> |
|
| Monday, January 22, 2018 |
|
|
Sanofi to Acquire Bioverativ for $11.6 Billion |
| Sanofi and Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, have entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Bioverativ for $105 per share in cash, representing an equity value of approximately $11.6 billion (on a fully diluted basis). The transaction was unanimously approved by both the Sanofi and Bioverativ Boards of Directors. more info >> |
|
| Friday, October 6, 2017 |
|
|
Sanofi: Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent(R) (alirocumab) |
| Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Court of Appeals for the Federal Circuit has ordered a new trial and vacated the permanent injunction in the dispute concerning Amgen's asserted patent claims for antibodies targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). This ruling means that Sanofi and Regeneron will continue marketing, selling and manufacturing Praluent(R) (alirocumab) injection in the U.S. more info >> |
|
| Thursday, February 13, 2014 |
|
|
A*STAR, NUS and NUH Join Forces to Understand Immune Erosion in Elderly |
| A*STAR's Singapore Immunology Network (SIgN) signed a three-year partnership with the National University of Singapore (NUS), National University Hospital (NUH) and Sanofi Pasteur to embark on a Phase IV clinical trial to understand age-related loss of immunity, known as immunosenescence, in elderly. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
U.S. Polo Assn. Returns as Official Apparel and Jersey Partner for Chestertons Polo in the Park in Downtown London
Jun 10, 2025 19:00 HKT/SGT
|
|
|
Supercomputer Fugaku retains first place worldwide in Graph500 rankings
Jun 10, 2025 19:47 JST
|
|
|
New HKTDC Chairman Frederick Ma keen to promote Hong Kong as best partner for global enterprises
Jun 10, 2025 17:31 HKT/SGT
|
|
|
ダイムラートラック、三菱ふそう、日野、トヨタ、三菱ふそうと日野の統合に関する最終合意を締結
Jun 10, 2025 16:30: JST
|
|
|
聯想控股副總裁于浩：在技術變革中錨定「長期主義」
Jun 10, 2025 15:37 HKT/SGT
|
|
|
联想控股副总裁于浩：在技术变革中锚定"长期主义"
Jun 10, 2025 15:28 HKT/SGT
|
|
|
Ai sẽ là người đầu tiên ghi danh vào lịch sử với tư cách là Nhà Vô Địch Thế Giới đầu tiên?!
Jun 10, 2025 14:00 HKT/SGT
|
|
|
Siapakah yang akan mengukir nama dalam sejarah sebagai "Juara Dunia Pertama"!
Jun 10, 2025 14:00 HKT/SGT
|
|
|
Siapakah yang akan mengukir namanya dalam sejarah sebagai “Juara Dunia Pertama”!
Jun 10, 2025 14:00 HKT/SGT
|
|
|
誰將成為名留青史的「初代世界冠軍」！
Jun 10, 2025 14:00 HKT/SGT
|
|
|
UK MOD Signs Protector Support Contract with GA-ASI
Jun 10, 2025 06:00 HKT/SGT
|
|
|
SRKay Consulting Group Releases Research Report: 'From Legal Frameworks to Successful Operations'--A Strategic Playbook for India Market Entry
Jun 9, 2025 17:00 HKT/SGT
|
|
|
Everest Medicines Presents Positive Results from Phase 1b/2a Clinical Trial of EVER001 for Primary Membranous Nephropathy at ERA 2025
Jun 9, 2025 12:52 HKT/SGT
|
|
|
雲頂新耀EVER001亮相ERA 2025 探索原發性膜性腎病治療新路徑
Jun 9, 2025 12:47 HKT/SGT
|
|
|
云顶新耀EVER001亮相ERA 2025 探索原发性膜性肾病治疗新路径
Jun 9, 2025 12:35 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
